(Q46654894)

24 December 2017

title

Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide (English)

1 reference

https://api.crossref.org/works/10.1002/EJI.1830010406

23 January 2024

1 reference

https://api.crossref.org/works/10.1002/EJI.1830010406

23 January 2024

author name string

D. Teitelbaum

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5157960

23 January 2024

A. Meshorer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5157960

23 January 2024

T. Hirshfeld

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5157960

23 January 2024

R. Arnon

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5157960

23 January 2024

M. Sela

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5157960

23 January 2024

language of work or name

English

0 references

publication date

1 August 1971

1 reference

24 December 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Feji.1830010406

1 reference

https://api.crossref.org/works/10.1002/EJI.1830010406

https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.1830010406

23 January 2024

1 reference

https://api.crossref.org/works/10.1002/EJI.1830010406

European Journal of Immunology

23 January 2024

published in

1 reference

24 December 2017

volume

1

1 reference

24 December 2017

page(s)

242-248

1 reference

24 December 2017

issue

4

1 reference

24 December 2017

Experimental allergic encephalomyelitis. Isolation of basic proteins and polypeptides from central nervous tissue

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

Studies on the chemical basis of the antigenicity of proteins. 5. Synthesis, characterization and immunogenicity of some multichain and linear polypeptides containing tyrosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

Basic proteins from the acidic extract of bovine spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

ENCEPHALOMYELITIS ACCOMPANIED BY MYELIN DESTRUCTION EXPERIMENTALLY PRODUCED IN MONKEYS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

Experimental Allergic Encephalomyelitis and Autoimmune Disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

Experimental allergic encephalomyelitis. An encephalitogenic basic protein from bovine myelin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

Basic encephalitogenic protein: A simplified purification on sulphoethyl-sephadex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

ENCEPHALITOGEN-INDUCED INHIBITION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS: PREVENTION, SUPPRESSION AND THERAPY.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

Protective action of the encephalitogen and other basic proteins in experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

Synthesis and Chemical Properties of Poly-α-Amino Acids

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

Synthesis, characterization, and acemization of poly-L-serine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

Ueber die Glycin-carbonsäure

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

EQUILIBRIUM ULTRACENTRIFUGATION OF DILUTE SOLUTIONS

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

Relationships between antibodies and experimental allergic encephalomyelitis. V. Antibodies and delayed hypersensitivity in production and prevention of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

Increases in serum lactate dehydrogenase in experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

Various Types of Acquired Resistance to Experimental ‘Allergic’ Encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

Encephalitogenic Factor in Experimental ‘Allergic’ Encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

Acquired resistance to experimental allergic encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

Suppression of Experimental Allergic Encephalomyelitis by Cytotoxic Drugs

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830010406

7 January 2021

Journal of Clinical Investigation

36

40

1069

Paterson P. Y.

1967

1 reference

https://api.crossref.org/works/10.1002/EJI.1830010406

Journal of Experimental Medicine

23 January 2024

38

116

169

Waksman B. H.

1961

1 reference

https://api.crossref.org/works/10.1002/EJI.1830010406

23 January 2024

Identifiers

1 reference

24 December 2017

1 reference

24 December 2017